ZIC5 knockdown induced melanoma cell death synergistically with the BRAF inhibitor PLX40324; accordingly, we assessed if a synergistic effect would be produced by treatment with low doses of LL‐Z1640‐2 or patulin with PLX4032. Here, BRAF is linked to melanoma.